XRAY250117P40000
- 0.00
- 0.000.00%
Dentsply Sirona Newsroom
BofA Securities Maintains Dentsply Sirona(XRAY.US) With Hold Rating, Announces Target Price $20
DENTSPLY SIRONA's Strategic Shift and Financial Uncertainties Justify Hold Rating
Evercore Maintains Dentsply Sirona(XRAY.US) With Hold Rating, Maintains Target Price $20
BofA Securities Maintains Dentsply Sirona(XRAY.US) With Hold Rating
Evercore Downgrades Dentsply Sirona(XRAY.US) to Hold Rating, Maintains Target Price $20
DENTSPLY SIRONA (XRAY) Was Downgraded to a Hold Rating at Evercore ISI
Dentsply Sirona Is Maintained at Overweight by Morgan Stanley
Dentsply Sirona Analyst Ratings
Morgan Stanley Maintains Dentsply Sirona(XRAY.US) With Buy Rating, Cuts Target Price to $23
DENTSPLY SIRONA (XRAY) Receives a Buy From Morgan Stanley
Mizuho Initiates Coverage On Dentsply Sirona With Neutral Rating, Announces Price Target of $21
Dentsply Sirona Is Maintained at Buy by UBS
Dentsply Sirona Analyst Ratings
UBS Lowers Price Target on DENTSPLY SIRONA to $27 From $35, Keeps Buy Rating
Stifel Nicolaus Remains a Hold on DENTSPLY SIRONA (XRAY)
J.P. Morgan Maintains Dentsply Sirona(XRAY.US) With Hold Rating, Cuts Target Price to $24
A Quick Look at Today's Ratings for Dentsply Sirona(XRAY.US), With a Forecast Between $20 to $30
Dentsply Sirona Is Maintained at Outperform by Barrington Research
Dentsply Sirona Analyst Ratings
Analysts' Opinions Are Mixed on These Healthcare Stocks: AMN Healthcare Services (AMN), DENTSPLY SIRONA (XRAY) and Haemonetics (HAE)